Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $853,422 - $1.2 Million
85,599 New
85,599 $1.14 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $114,125 - $225,433
20,128 New
20,128 $164,000
Q2 2021

Aug 16, 2021

SELL
$22.3 - $36.02 $170,215 - $274,940
-7,633 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $201,358 - $390,427
7,633 New
7,633 $254,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.